BioSpace News Archive

Job Trends

Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care

Abbott (NYSE: ABT) today announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK) in people with chronic limb-threatening ischemia (CLTI).

October 25, 2023
·
5 min read
Genetown

Vesigen Highlights Data Demonstrating Directed Tropism of Non-Viral Delivery Platform at the 30th Annual Congress of the European Society of Gene & Cell Therapy

Vesigen Therapeutics, Inc. today presented data highlighting the potential of the Company’s non-viral ARMM (ARrestin-domain 1 Mediated Microvesicles) technology to overcome fundamental delivery challenges that limit the clinical application of emerging treatment modalities.

October 25, 2023
·
3 min read
Business

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

MDxHealth SA, a commercial-stage precision diagnostics company, announced it will release its financial results for the third quarter and nine-month period ended September 30, 2023, after market close on Wednesday, November 8, 2023.

October 25, 2023
·
2 min read
Pharm Country

Regeneron Announces Investor Conference Presentations - October 25, 2023

Regeneron Pharmaceuticals, Inc. will webcast management participation as follows.

October 25, 2023
·
1 min read
Business

AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS

Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, October 31, 2023, before the opening of the U.S. financial markets.

October 25, 2023
·
2 min read
Business

Edwards Lifesciences Reports Third Quarter 2023 Results

Edwards Lifesciences reported financial results for the quarter ended Sept. 30, 2023.

October 25, 2023
·
21 min read
Business

Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 third quarter financial results on Wednesday, November 8, 2023, after the close of the U.S. financial markets.

October 25, 2023
·
2 min read
Business

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that the Company will report third quarter 2023 financial results on Wednesday, November 8, 2023.

October 25, 2023
·
1 min read
Business

Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third quarter 2023 financial results after the market closes on Wednesday, November 1, 2023.

October 25, 2023
·
1 min read
BioMidwest

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

OPKO Health, Inc. will present late-breaking clinical data on RAYALDEE® extended-release calcifediol at the American Society of Nephrology Kidney Week in Philadelphia on Thursday, November 2, 2023.

October 25, 2023
·
4 min read